ArticleFrontiers in molecular biosciences2021

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma.

Fangfang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.